SYTL1

SYTL1 (JFC1/Slp1) is a tandem C2-domain Rab27a effector that couples phosphoinositide-marked membranes to regulated vesicle docking and exocytosis, most extensively characterized in neutrophil granule secretion (PMID:11278853, PMID:16004602, PMID:18939952). Its C2A domain binds 3'-phosphoinositides (PIP3 and PI(3,4)P2) and directs plasma-membrane and secretory-vesicle association in living cells, an interaction reversed by PI3K inhibition (PMID:11278853, PMID:12189202). Membrane targeting is gated by the PI3K/Akt axis: Akt directly phosphorylates JFC1 at Ser241, driving its dissociation from membranes into the cytosol, whereas Rab27a binding strongly suppresses this phosphorylation (PMID:15998322). JFC1 also possesses intrinsic Mg2+-dependent ATPase activity that is independent of its phosphoinositide binding (PMID:11553774). In neutrophils, JFC1 colocalizes with Rab27a on docked and predocked granules and is required for azurophilic (myeloperoxidase) granule exocytosis, defining effector specificity among Rab27a-dependent secretion events (PMID:18939952). It executes this by recruiting the RhoA-GAP GMIP to secretory granules to locally depolymerize cortical actin and permit granule transit to the plasma membrane (PMID:22438581), and it independently controls directional chemotaxis by recycling Rac1-GTP away from the neutrophil uropod in a Rab27a-independent manner (PMID:30748033). Beyond neutrophils, JFC1 acts as a Rab8a effector through binding EPI64 to regulate endosomal membrane recycling (PMID:22219378), regulates androgen-dependent prostatic acid phosphatase secretion (PMID:16004602), and is exploited by Anaplasma phagocytophilum, whose PI3P-enriched inclusions recruit JFC1 via its C2A domain (PMID:38110148). SYTL1 transcription is activated by NF-κB/TNFα through three functional promoter sites (PMID:12137562).

1. 2001 Medium

   Establishing that JFC1 physically links to the NADPH oxidase machinery and selectively binds 3'-phosphoinositides positioned it as a phosphoinositide-responsive adaptor at the neutrophil plasma membrane.

   Evidence Yeast two-hybrid, affinity pulldown with neutrophil cytosol and recombinant proteins, lipid-binding assays, and subcellular fractionation

   PMID:11278853

   Open questions at the time

   • Functional consequence of the p67(phox) interaction for oxidase activity not tested
   • Single lab; reciprocal binding not extended in vivo
2. 2001 High

   Identifying intrinsic Mg2+-dependent ATPase activity defined an enzymatic property of JFC1 distinct from its lipid-binding function, raising the question of what this activity drives mechanistically.

   Evidence Photoaffinity ATP-analog labeling, in vitro ATPase kinetics, and truncation mutagenesis

   PMID:11553774

   Open questions at the time

   • Cellular substrate or physiological role of the ATPase activity unresolved
   • Whether ATP hydrolysis is required for any membrane-trafficking step untested
3. 2002 High

   Mapping phosphoinositide binding and membrane targeting to the C2A domain explained how PI3K signaling spatially controls JFC1 recruitment.

   Evidence Domain truncation, in vitro lipid binding, and live-cell imaging with PI3K inhibition

   PMID:12189202

   Open questions at the time

   • Role of the calcium modulation of C2A membrane binding in physiological secretion not defined
4. 2002 High

   Demonstrating NF-κB/TNFα control of the JFC1 promoter linked its expression to inflammatory signaling, relevant to its neutrophil role.

   Evidence EMSA/supershift, luciferase reporters, and dominant-negative IκB in transfected cells

   PMID:12137562

   Open questions at the time

   • Endogenous transcriptional induction kinetics during inflammation not characterized
5. 2005 Medium

   Identifying JFC1 as a Rab27a effector regulating PSAP secretion connected its phosphoinositide-binding module to Rab27a-dependent regulated exocytosis.

   Evidence Overexpression/dominant-negative constructs, immunofluorescence, ELISA secretion assays, and PI3K inhibition in LNCaP cells

   PMID:16004602

   Open questions at the time

   • Direct Rab27a-JFC1 binding interface not mapped here
   • Mechanism distinguishing PSAP from PSA granule targeting unresolved
6. 2005 High

   Showing Akt phosphorylates Ser241 to release JFC1 from membranes, and that Rab27a binding blocks this, defined a regulatory switch integrating PI3K/Akt with Rab27a control of membrane residence.

   Evidence HPLC-MS/MS phosphosite mapping, in vitro kinase assay, mutagenesis, and live-cell imaging

   PMID:15998322

   Open questions at the time

   • How Rab27a binding sterically or allosterically protects Ser241 not structurally defined
7. 2008 High

   Genetic and siRNA loss-of-function established JFC1 as the Rab27a effector specifically required for azurophilic granule exocytosis, demonstrating effector-specific division of labor among Rab27a partners.

   Evidence siRNA knockdown, TIRF colocalization, MPO/gelatinase secretion assays, and Jinx mouse neutrophils

   PMID:18939952

   Open questions at the time

   • Molecular basis for granule-subset selectivity not yet explained at this stage
8. 2012 High

   Discovery that JFC1 recruits the RhoA-GAP GMIP to granules to locally depolymerize cortical actin provided the mechanism by which granules traverse the actin cortex to the plasma membrane.

   Evidence Co-IP/proteomics, siRNA, RhoA activation assays, live-cell microscopy, and JFC1-knockout neutrophils

   PMID:22438581

   Open questions at the time

   • Whether GMIP recruitment is Rab27a-dependent not fully delineated
   • Coordination with SNARE-mediated fusion machinery not addressed
9. 2012 Medium

   Identifying JFC1 as a Rab8a effector via EPI64 binding extended its function beyond Rab27a to endosomal membrane recycling.

   Evidence Direct binding/co-localization, uncoupling mutants, RabGAP activity assays, and vacuole-formation phenotype

   PMID:22219378

   Open questions at the time

   • Physiological setting of the EPI64-JFC1-Rab8a axis outside the cell model unclear
   • Direct JFC1-EPI64 affinity and stoichiometry not quantified
10. 2019 High

    Demonstrating Rab27a-independent JFC1 binding to Rac1-GTP and uropod recycling separated JFC1's chemotaxis function from its granule-secretion function.

    Evidence JFC1-knockout mouse neutrophils, STORM microscopy, Co-IP, and in vitro/in vivo chemotaxis assays

    PMID:30748033

    Open questions at the time

    • Structural basis of the JFC1-Rac1-GTP interaction not defined
    • How the same protein partitions between Rab27a-dependent and -independent pools unresolved
11. 2022 Medium

    ELK1-HDAC2 promoter repression of SYTL1 added an epigenetic transcriptional control layer relevant in bladder cancer.

    Evidence ChIP/promoter binding, siRNA, western blot, and xenograft model

    PMID:36107384

    Open questions at the time

    • Downstream secretory consequences of SYTL1 repression in tumor cells not mechanistically traced
12. 2023 Medium

    WTAP/YTHDF2-mediated m6A degradation of SYTL1 mRNA defined a post-transcriptional regulatory mechanism controlling SYTL1 abundance.

    Evidence RIP-qPCR and actinomycin D mRNA-stability chase

    PMID:37933909

    Open questions at the time

    • m6A site location on SYTL1 mRNA not mapped
    • Cellular phenotype downstream of altered SYTL1 levels not established
13. 2023 Medium

    Localization of JFC1 to PI3P-enriched Anaplasma inclusions via its C2A domain showed that an intracellular pathogen co-opts the phosphoinositide-binding mechanism, and that Nexinhib20 blocks infection.

    Evidence shRNA knockdown, C2A truncation, live imaging, and Nexinhib20 inhibition in HL-60 cells

    PMID:38110148

    Open questions at the time

    • Whether JFC1 supports inclusion biogenesis or nutrient acquisition unclear
    • Role of the ATPase activity in this context untested
14. 2023 Low

    A proposed Rab27a/SYTL1/CD81 complex links SYTL1 to exosome secretion and tumor immune evasion.

    Evidence Co-immunoprecipitation, in vivo tumor model, and exosome secretion assays

    PMID:38136327

    Open questions at the time

    • Single Co-IP without reciprocal or structural validation of complex architecture
    • SYTL1's specific molecular contribution within the complex not resolved
    • Direct vs indirect CD81 interaction undefined
15. 2025 High

    Demonstrating Rac1-independent JFC1 control of a CD11b+/β2-integrin granule subset further dissected its secretory functions, showing distinct pathways for integrin mobilization versus Rac1 recycling.

    Evidence JFC1-knockout neutrophils, Nexinhib20, 3D enhanced-resolution microscopy, and FRET-based Rac1 activity assays

    PMID:39883854

    Open questions at the time

    • Granule-subset selectivity determinants for CD11b+ granules not identified
    • Whether GMIP/actin mechanism applies to this subset untested

• How a single effector partitions among its distinct Rab27a-dependent granule-secretion, Rab8a-dependent recycling, and Rab27a-independent Rac1-recycling functions, and the physiological role of its intrinsic ATPase activity, remain open.
• No structural model of JFC1 bound to Rab27a, Rab8a, or Rac1-GTP
• Functional substrate or trafficking role of the ATPase activity unknown
• Mechanism allocating JFC1 between competing effector pools undefined